PHARMACOEPIDEMIOLOGY, PATIENT SAFETY AND INDIVIDUALIZED DRUG THERAPY
CHANCES AND CHALLENGES OF GERONTOPHARMACOLOGY
CURRENT CHALLENGES IN DRUG AND PATIENT SAFETY: THE ROLE OF ELECTRONIC DRUG INFORMATION SYSTEMS
IMPACT OF CYP2C19 GENOTYPING FOR IDENTIFICATION OF PATIENTS WITH ATTENUATED ANTIPLATELET RESPONSE TO CLOPIDOGREL
NSAID ANALGESICS ATTENUATE ASPIRIN-INDUCED PLATELET INHIBITION IN VITRO: LARGE DIFFERENCES BETWEEN INDIVIDUAL COMPOUNDS
INTERACTION OF THE ANTIGLAUCOMA PROSTANOID LATANOPROST WITH THE PROSTAGLANDIN TRANSPORTER OATP2A1
THE INFLUENCE OF HAPLOTYPES ON ABCC2 GENE EXPRESSION AND TRANSPORT FUNCTION
POSTMENOPAUSAL ESTROGEN MONOTHERAPY ASSOCIATED BREAST CANCER RISK IS MODIFIED BY CYP17A1_-34_T>C POLYMORPHISM
CAPSAICIN, THERMOGENESIS AND ADIPOSE TISSUE AND SKELETAL MUSCLE METABOLISM
PLASMA CONCENTRATIONS OF PROTEASE INHIBITORS OVER DIFFERENT AGE CLASSES
STEADY STATE EFAVIRENZ PHARMACOKINETICS PROFILE AMONG HIV PATIENTS IN ETHIOPIA
THE AUTO INDUCTION OF EFAVIRENZ METABOLISM AND THE RESULTING EFFECT ON THE EFAVIRENZ STEADY STATE LEVELS IN TANZANIAN PATIENTS
IDENTIFICATION OF INCREASED SERUM CONCENTRATIONS OF LINEZOLID IN PATIENTS WITH COMMON PREDISPOSING RISK FACTORS FOR ADVERSE DRUG REACTION BY SYNERGISTIC USE OF CLINICAL PHARMACOLOGICAL WARD ROUNDS AND THERAPEUTIC DRUG MONITORING (TDM)
DETERMINANTS OF VERY LOW VORICONAZOLE CONCENTRATIONS IN ROUTINE THERAPEUTIC DRUG MONITORING (TDM)
RISK OF INCIDENT AUTOIMMUNE DISEASES AFTER HEPATITIS B VACCINATION - A LARGE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE
INFLUENCE OF UDP-GLUCURONOSYLTRANSFERASE (UGT)-POLYMORPHISMS ON ATORVASTATIN LACTONIZATION AND IMPLICATIONS FOR DRUG RESPONSE
MUSCULAR SYMPTOMS IN FAMILY PRACTICE PATIENTS WITH OR WITHOUT STATIN PRESCRIPTION - A CROSS-SECTIONAL STUDY
BAROREFLEX LOADING DURING ALPHA-2 ADRENORECEPTOR STIMULATION UNMASKS IMPAIRED PARASYMPATHETIC HEART RATE RESERVE IN MIDDLE-AGED SUBJECTS
TELOMERE LENGTH AND LEFT VENTRICULAR STRUCTURE IN HYPERTENSIVE PATIENTS UNDER PHARMACOTHERAPY ACCORDING TO GUIDELINES
THROMBIN INDUCES EXPRESSION OF FUNCTIONALLY ACTIVE P2Y12 ADP RECEPTOR IN HUMAN VASCULAR SMOOTH MUSCLE CELLS
ERBITUX IN COMBINATION WITH CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUALIZATION INCREASES PATIENT BENEFIT
SIGNIFICANCE OF DRUG TRANSPORTERS FOR THE SYNERGISM OF FOLFOX CHEMOTHERAPY
PHARMACOKINETICS AND TOXICITY PROFILE OF BENDAMUSTINE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
EVALUATION OF THE PHYSIOLOGY-BASED PHARMACOKINETIC (PBPK) MODEL PK-SIM® IN CHILDREN RECEIVING HIGH-DOSE METHOTREXATE
SAFE COADMINISTRATION OF THE NK1 RECEPTOR ANTAGONIST APREPITANT AFTER HIGH-DOSE MELPHALAN CHEMOTHERAPY: RESULTS FROM A RANDOMIZED PLAZEBO-CONTROLLED STUDY IN PATIENTS WITH MULTIPLE MYELOMA
CARDIOVASCULAR EVENTS IN CLINICAL TRIALS IN PATIENTS WITH MULTIPLE MYELOMA - SUSAR OR NATURAL COURSE OF DISEASE?
INVOLVEMENT OF THE MICRORNA LET-7 IN THE REGULATION OF PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1 EXPRESSION IN OVARIAN CANCER CELLS
CONVECTION-ENHANCED DELIVERY OF NON-PEGYLATED LIPOSOMES OF TOPOTECAN AND GADODIAMIDE IN MALIGNANT GLIOMA
PHARMACOKINETICS, PHARMACODYNAMICS AND THE AGING KIDNEY
EVALUATION OF QUALITY AND APPROPRIATENESS OF PAIN MEDICATION IN NURSING HOME RESIDENTS: A PILOT STUDY IN GERMANY
MEDICATION AND FALLS IN OLDER HOSPITAL INPATIENTS - A CASE-CONTROL STUDY
IMPACT OF DRUG INTERACTIONS ON THE RISK OF HIP FRACTURE ASSOCIATED WITH BENZODIAZEPINE USE
ORTHOSTATIC HYPOTENSION (OH) IN GERIATRIC INPATIENTS - PRECIPITATING MEDICATION AND CLINICAL CONSEQUENCES
PRESCRIBING PATTERNS OF PAIN MEDICATION TO ELDERLY NURSING HOME RESIDENTS IN GERMANY
DEVELOPMENT OF A GERMAN LIST OF POTENTIALLY INAPPROPRIATE MEDICATION IN THE ELDERLY
INAPPROPRIATE MEDICATION PRESCRIBING FOR ELDERLY OUTPATIENTS IN SAXONY - AN EVALUATION OF CLAIMS DATA
PREDICTION OF PARTIAL METABOLIC CLEARANCE OF MIDAZOLAM FROM PARTIAL AUC AS A MARKER OF CYP3A4 ACTIVITY
PHARMACOKINETICS OF THE SOLVENT SULFOBUTYLETHER-BETA-CYCLODEXTRIN (SBECD) IN PATIENTS WITH CHRONIC RENAL FAILURE DURING HAEMODIALYSIS TREATMENT WITH TWO SYSTEMS AND HAEMODIAFILTRATION
PLASMAKINETICS OF FENTANYL IN ORTHOTOPIC LTX
THE ANTICOAGULANT IDRAPARINUX: IS THE EXTENSIVE HALF LIFE OF 60 DAYS THE CAUSE OF BLEEDING COMPLICATIONS
DOSING ADJUSTMENT ACCORDING TO DETTLI'S RULE: MEASURED PHARMACOKINETICS IN KIDNEY PATIENTS VERSUS URINARY RECOVERY IN HEALTHY INDIVIDUALS
CASE REPORT: NON-SUFFICIENT CONCENTRATIONS OF OLANZAPINE IN A PATIENT UNDER OLANZAPINE MELTING TABLETS
REPEATED HONEY CONSUMPTION DOES NOT CHANGE CYP3A4 ACTIVITY IN HUMANS
PHARMACOKINETICS AND SAFETY OF COMBINED ADMINISTRATION OF PRILOCAINE AND ROPIVACAINE IN BRACHIAL PLEXUS ANAESTHESIA
EFFECTS OF STEADY-STATE ENOXACIN, A BROAD-SPECTRUM FLUOROQUINOLONE, ON SINGLE-DOSE PHARMACOKINETICS OF ROFLUMILAST AND ROFLUMILAST N-OXIDE
WARFARIN PHARMACODYNAMICS AND PHARMACOKINETICS ARE NOT AFFECTED BY THE SOLUBLE GUANYLATE CYCLASE STIMULATOR RIOCIGUAT (BAY 63-2521)
SHORT-TERM EFFECT OF EFAVIRENZ ON IN VITRO METABOLISM OF MIDAZOLAM BY HUMAN LIVER MICROSOMES
PHARMACOGENOMICS OF CYP3A4: A PATHWAY ORIENTED CANDIDATE GENE APPROACH
ARE THERE DIFFERENCES BETWEEN HEALTHY VOLUNTEERS AND HIV-INFECTED PATIENTS IN THE ACTIVITIES OF CYP3A, CYP2D6 AND P-GLYCOPROTEIN?
PHENOTYPE-GENOTYPE ANALYSIS OF CYP1A2 IN HEALTHY NON-SMOKING VOLUNTEERS
IDENTIFICATION AND CYP DEPENDENT METABOLISM OF ENDOGENOUS FATTY ACID DERIVATIVES IN HUMAN PLASMA
CONVERSION OF AZATHIOPRINE TO MERCAPTOPURINE IS NOT A FUNCTION OF GENDER
SYSTEMATIC ANALYSIS OF NUCLEOSIDE DIPHOSPHATE KINASE ISOFORM A AND B IN HUMAN TISSUES
PHARMACOKINETICS AND METABOLISM OF FLUPIRTINE IN MAN GENOTYPED FOR NAT2, UGT1A1 AND GSTP1
INFLUENCE OF CYCLOOXYGENASE INHIBITORS ON THE FUNCTION OF THE PROSTAGLANDIN TRANSPORTER OATP2A1 EXPRESSED IN HUMAN GASTRIC MUCOSA
THE INFLUENCE OF FREQUENT GENETIC VARIATIONS ON THE TRANSPORT ACTIVITY OF OATP1B1
EXPRESSION AND LOCALIZATION OF OATP3A1 AND OATP5A1 IN MALIGNANT AND NON-MALIGNANT BREAST TISSUE
INTERINDIVIDUAL VARIABILITY OF MULTIDRUG RESISTANCE PROTEIN 2 (ABCC2) EXPRESSION IN HUMAN LIVER: IMPACT OF ABCC2 POLYMORPHISMS
POTENTIAL OF NOVEL ANTIRETROVIRALS TO MODULATE EXPRESSION AND FUNCTION OF ABC-TRANSPORTERS
EFFECT OF CAVEOLIN-1 KNOCKDOWN ON THE ACTIVITY OF BREAST CANCER RESISTANCE PROTEIN
MULTIPLE ELECTRODE PLATELET AGGREGOMETRY COMPARED WITH LIGHT TRANSMISSION AGGREGOMETRY AND VERIFYNOW P2Y12 ASSAY FOR ASSESSMENT OF PLATELET REACTIVITY IN PATIENTS TREATED WITH CLOPIDOGREL AFTER PCI
ASSAY TO STUDY DRUG-DRUG INTERACTIONS BETWEEN CITALOPRAME AND ADDITIONALLY PRESCRIBED PSYCHOTROPIC DRUGS IN HUMAN LIVER MICROSOMES
AN LC/MS/MS ASSAY FOR THE INTRACELLULAR QUANTIFICATION OF CISPLATIN IN VITRO
DEVELOPMENT OF A SELECTIVE AND SENSITIVE HPLC/FLUORESCENCE ASSAY FOR QUANTIFICATION OF DOXORUBICIN IN RAT PLASMA RELEASED FROM NANOPARTICLES
SELECTIVE AND SENSITIVE QUANTIFICATION OF THE HDAC-INHIBITOR VORINOSTAT (SAHA) IN PLASMA AND PBMCS BY HPLC COUPLED TO ELECTROSPRAY TANDEM MASS SPECTROMETRY (LC/MS/MS)
SIMULTANEOUS DETERMINATION OF PREDNISOLONE AND CICLOSPORINE IN SERUM SAMPLES OF PATIENTS WITH LC/MS/MS
TARGETED STABLE-ISOTOPE DILUTION GC-MS/MS DETERMINATION OF THE ENDOCANNABINOID ANANDAMIDE AND OTHER FATTY ACID ETHANOL AMIDES IN HUMAN PLASMA
STUDY DISCONTINUATIONS IN CLINICAL TRIALS AND DATA MONITORING COMMITTEES
PHARMACOVIGILANCE IN CLINICAL TRIALS AFTER POINT IN TIME OF AUTHORISATION
A SIX-YEARS REVIEW OF INCIDENCE OF ADVERSE EVENTS IN EARLY PHASE I - A COMPARISON BETWEEN FIRST-IN-MAN STUDIES, BIOAVAILABILITY AND/OR FOOD AND INTERACTION STUDIES
COAGULATION DISTURBANCES IN CLINICAL TRIALS WITH ANTICOAGULANTS - INSUFFICIENT EFFICACY, WELL-KNOWN ADVERSE REACTIONS OR ‘SUSAR'S’?
LEVOFLOXACIN CAN BE USED EFFECTIVELY AS A POSITIVE CONTROL IN THOROUGH QT/QTC STUDIES IN HEALTHY VOLUNTEERS
TQT STUDIES: THEIR IMPACT ON DRUG DEVELOPMENT AND THE KEY ELEMENTS OF A SUCCESSFUL TQT STUDY
THE INNOVATION CRISIS OF THE PHARMACEUTICAL INDUSTRY WITH A PARTICULAR EMPHASIS ON GERMANY
RANDOMIZED CONTROLLED DOUBLE BLIND CLINICAL TRIALS VERSUS OPEN TRIALS
DOSE-RELATED REFERENCE RANGES FOR THERAPEUTIC DRUG MONITORING IN HUMAN BLOOD SPECIMENS
ADHERENCE TO GUIDELINES OF ANTITHROMBOTIC TREATMENT OF ATRIAL FIBRILLATION AND REASONS FOR GUIDELINE VIOLATION
THE NEWLY DEVELOPED COMPUTERIZED DECISION SUPPORT SYSTEM AIDPAINCARE® IMPROVES GUIDELINE ADHERENCE IN TUMOUR PAIN THERAPY
A THRESHOLD VALUE TO INCREASE THE CLINICAL RELEVANCE OF OVERDOSE ALERTS
MODULATORS FOR ELECTRONIC RISK PREDICTION OF ADVERSE DRUG EVENTS - PATIENT CHARACTERISTICS IN DRUG-DRUG INTERACTIONS AND DOSE ADJUSTMENTS
IMPACT OF ELECTRONIC DECISION SUPPORT FOR ECONOMIC PRESCRIBING IN A HOSPITAL PROVIDING TERTIARY CARE
EVALUATION OF MEDICATION SAFETY IN MEDICAL INPATIENTS WITH THREE DIFFERENT PRESCRIPTION SUPPORT SOLUTIONS
PHYNX: AN OPEN SOURCE SOFTWARE SOLUTION SUPPORTING WEB-BASED PATIENT-LEVEL DATA REVIEW FOR DRUG SAFETY DATABASE STUDIES
FINDING WITHOUT SEARCHING: REAL-TIME ANNOTATION OF DRUG INFORMATION IN WEB DOCUMENTS
IS THE ADVERSE REACTION SECTION IN SPECIFIC PRODUCT CHARACTERISTICS OF NEWLY APPROVED DRUGS A MIRROR OF INADEQUATE SUSAR REPORTING?
PATIENTS' PREFERENCES FOR WRITTEN INFORMATION ABOUT EFFECTS AND UNDESIRABLE SIDE EFFECTS OF DRUGS
DRUGS BEHIND THE WHEEL - WHY ESPECIALLY ELDERLY PEOPLE ARE AT RISK
SCORED TABLETS: FACILITATED SWALLOWING OR FRACTIONAL DOSING?
GERMAN HEALTH CARE SYSTEM - UNMET PATIENT INFORMATION NEEDS
ACCEPTATION OF A DRUG INFORMATION SERVICE - A PATIENT EVALUATION
FOOD SUPPLEMENTS FOR EYE DISEASES - AN ANALYSIS OF PATIENT REQUESTS
ADVERSE DRUG REACTIONS: THE MOST COMMONLY INVOLVED DRUGS AND ORGAN SYSTEMS IN PHARMACOVIGILANCE REPORTS AT THE UNIVERSITY HOSPITAL ZURICH
INCONSISTENT USE OF PROTON PUMP INHIBITOR PROPHYLAXIS FOR PREVENTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED GASTROINTESTINAL DAMAGE (NSAID GID) IN HIGH RISK PATIENTS
HOW TO PRIORITISE MEDICATION HANDLING ERRORS TO GUIDE QUALITY IMPROVEMENT
PREVENTION OF ADMINISTRATION ERRORS AND POTENTIAL COST SAVINGS IN PAEDIATRIC NEUROLOGICAL PATIENTS
TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) WITH SITAGLIPTIN-EFFICACY AND SAFETY IN A REAL-LIFE SETTING
INFLUENCE OF GENETIC VARIANTS ON THERAPEUTIC OUTCOME IN PATIENTS WITH DIABETES MELLITUS TYPE 2
INFLUENCE OF DIETARY FAT ON THE PERIPHERAL ENDOCANNABINOID-SYSTEM IN LEAN AND OBESE HUMAN SUBJECTS
CONVECTION-ENHANCED DELIVERY FOR LOCAL TARGETED THERAPY OF INTRACTABLE EPILEPSY
PROBLEMS IN CHOOSING THE RIGHT EPIDEMIOLOGICAL RESEARCH METHOD
IN VITRO DETECTION AND CHARACTERIZATION OF DRUG HYPERSENSITIVITY USING FLOW CYTOMETRY
SEVERE CHOLESTATIC HEPATITIS AFTER FIRST CYCLE OF TEMOZOLOMIDE RADIOCHEMOTHERAPY IN A GLIOBLASTOMA PATIENT
PATIENT SELF-MEDICATION AND SERIOUS ADVERSE DRUG REACTIONS (ADRS)
MHH CENTER OF DRUG SAFETY (ZAS)
PREVENTABILITY OF ADVERSE DRUG REACTIONS LEADING TO HOSPITAL ADMISSION — ASSESSMENT OF INTER-RATER VARIABILITY WITHIN THE NETWORK OF REGIONAL PHARMACOVIGILANCE CENTERS
ADVERSE DRUG REACTIONS IN A COMPLEMENTARY MEDICINE HOSPITAL
MEASURES TO IMPROVE SAFETY IN DRUG THERAPY - THE FEDERAL MINISTRY OF HEALTH ACTION PLAN FOR IMPROVEMENT OF MEDICATION SAFETY (2008/2009)
FATAL MULTIPLE ORGAN FAILURE IN ASSOCIATION WITH A SINGLE INTRAMUSCULAR INJECTION OF PIROXICAM AND DEXAMETHASONE AND ORAL INTAKE OF DICLOFENAC
FATAL ADVERSE DRUG REACTIONS: A SYSTEMATIC REVIEW